| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0A090J7P6 | ERCC5-202 protein; | ERCC5-202; | NULL | 1640 | human |
| A0A061DEZ3 | MHC class I antigen; | HLA-C; | NULL | 366 | human |
| A0A090N8I7 | LOC401434; | LOC401434; | NULL | 207 | human |
| A0A090N8F8 | Adenylate cyclase activating polypeptide 1 (Pituitary) receptor type I; | ADCYAP1R1; | NULL | 468 | human |
| A0A059RHT6 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| A0A059RH94 | Cytochrome b; | CYTB; | NULL | 380 | human |
| H0YLW8 | Proline-serine-threonine phosphatase-interacting protein 1; Fragment; | PSTPIP1; | NULL | 209 | human |
| H0Y5M6 | Serine/threonine-protein kinase D3; Fragment; | PRKD3; | NULL | 185 | human |
| A0A090N8Z7 | FAST kinase; | FASTK; | NULL | 549 | human |
| A0A059RS62 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| A0A059RKB7 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| A0A060S0X7 | MHC class I antigen; Fragment; | HLA-C; | NULL | 273 | human |
| H0YNV9 | Fibrous sheath-interacting protein 1; Fragment; | FSIP1; | NULL | 15 | human |
| H3BM69 | Immunoglobulin superfamily-containing leucine-rich repeat protein 2; Fragment; | ISLR2; | NULL | 114 | human |
| H0YLQ8 | Leucine-rich repeat-containing protein 49; Fragment; | LRRC49; | NULL | 116 | human |
| H3BMM1 | Unconventional myosin-IXa; | MYO9A; | NULL | 1301 | human |
| H3BM44 | Protein NDRG4; Fragment; | NDRG4; | NULL | 81 | human |
| A0A090D8A2 | MHC class I antigen; Fragment; | HLA-A; | NULL | 181 | human |
| H3BS76 | Dysbindin domain-containing protein 1; Fragment; | DBNDD1; | NULL | 79 | human |
| H3BPW9 | Enhancer of mRNA-decapping protein 3; Fragment; | EDC3; | NULL | 253 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |